Rubric Capital Management LP Kura Oncology, Inc. Transaction History

Rubric Capital Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$12.22 - $19.57 $4.89 Million - $7.83 Million	-400,000 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$15.42 - $21.72 $2.6 Million - $3.66 Million	168,519 Added 72.8%	400,000 $7.49 Million
Q2 2021 Aug 13, 2021	BUY	$20.85 - $29.88 $4.83 Million - $6.92 Million	231,481 New	231,481 $4.83 Million

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $603M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Rubric Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rubric Capital Management LP with notifications on news.